Skip to main content

Showing 11 - 20 of 34 results

Spotlight

March 31, 2023

Optimizing the Use of Gabapentin: A Special Drive to Deprescribe Podcast

Medication optimization is a hot topic in post-acute and long-term care and a focus of AMDA’s very popular Drive to Deprescribe (D2D) initiative. Now practitioners have yet another opportunity to address their deprescribing challenges with a new quarterly D2D podcast. The first program addresses Optimizing...
JAMDA

June 27, 2022

Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer’s Disease and Related Dementias: A Cross-Sectional Analysis

We examined the association between nursing home (NH) characteristics and whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing to residents with Alzheimer’s disease and related dementias (ADRD). We then measured the likelihood that NHs who were high (low) prescribers o...